CADTH - CoLab
Created and funded by Canada’s federal, provincial, and territorial governments, CDA-AMC is responsible for driving better coordination, alignment, and public value within Canada’s drug and …
About CADTH: CADTH is an independent, not-for-profit organization responsible for providing Canada’s health care decision-makers with objective evidence to help make informed decisions about the …
Through the Common Drug Review (CDR) process, CADTH undertakes reviews of drug submissions, resubmissions, and requests for advice, and provides formulary listing recommendations to all …
The CADTH Canadian Drug Expert Committee (CDEC) recommends that indacaterol/mometasone furoate should be reimbursed for once-daily maintenance treatment of asthma in patients aged 12 …
Although Health Canada reviewers had concerns with the study design of CARE-MS II, they concluded that there is a potential clinical efficacy benefit in using alemtuzumab in RRMS patients who have …
The 2003 Canadian Diabetes Association (CDA) guidelines do not address the use of open-loop insulin delivery systems. They do, however, provide direction on the use of CSII and CGMS.
to help make informed decisions about the optimal use of drugs, medical devices, diagnostics, and procedures in our health care system. Funding: CADTH receives funding from Canada’s federal, …
About CADTH:CADTH is an independent, not-for-profit organization responsible for providing Canada’s health care decision-makers with objective evidence to help make informed decisions about the …
Technology Standard tourniquets are not effective for controlling a junctional hemorrhage, which is bleeding from the areas at the junction of the trunk and its appendages. However, junctional …
About CADTH: CADTH is an independent, not-for-profit organization responsible for providing Canada’s health care decision-makers with objective evidence to help make informed decisions about the …